STOCK TITAN

Omeros Corporation - OMER STOCK NEWS

Welcome to our dedicated news page for Omeros Corporation (Ticker: OMER), a resource for investors and traders seeking the latest updates and insights on Omeros Corporation.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Omeros Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Omeros Corporation's position in the market.

Rhea-AI Summary
Omeros Corporation announced financial results for Q2 2023, reporting a net loss of $37.3 million, or $0.59 per share, compared to a net loss of $30.8 million, or $0.49 per share, in the prior year quarter. The company earned OMIDRIA royalties of $10.7 million on U.S. net sales of $35.7 million. Omeros had $341.3 million of cash and short-term investments available for operations and debt servicing as of June 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.67%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.31%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.42%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.2%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.02%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.31%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.28%
Tags
Omeros Corporation

Nasdaq:OMER

OMER Rankings

OMER Stock Data

217.86M
51.71M
4.38%
43.22%
22.93%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Seattle

About OMER

omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.